| scholarly article | Q13442814 |
| P2093 | author name string | Mark Foster | |
| Thomas Meier | |||
| Michael Erb | |||
| Philipp Weyermann | |||
| Holger Herzner | |||
| Alexandre Briguet | |||
| Andreas von Sprecher | |||
| Josef P Magyar | |||
| Cyrille Lescop | |||
| Isabelle Courdier-Fruh | |||
| Hervé Siendt | |||
| Marco Henneböhle | |||
| Reto Bolliger | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5176-5181 | |
| P577 | publication date | 2005-09-26 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy | |
| P478 | volume | 15 |
| Q46442267 | Calpain inhibitors alter the excitable membrane properties of cultured aplysia neurons |
| Q37857282 | Calpain inhibitors: a survey of compounds reported in the patent and scientific literature |
| Q37017587 | Chemistry and biology of multicomponent reactions. |
| Q38209315 | Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells |
| Q80216232 | Flow cytometric measurement of calpain activity in living cells |
| Q24644090 | Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy |
| Q37174711 | Leupeptin-based inhibitors do not improve the mdx phenotype. |
| Q33869468 | MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut |
| Q34194374 | Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors |
| Q41940642 | Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids |
| Q40839491 | Targeting host calpain proteases decreases influenza A virus infection. |
| Q38104503 | The physiological response of protease inhibition in dystrophic muscle |
Search more.